Dermatoporosis: An emerging syndrome;Dermatoporode: Un syndrome émergent

Revue Medicale Suisse

Volumn 4, Issue 155, 2008, Pages 1078-1082

  Kaya, Gürkan ^a  

^a Service de Dermatologie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID;

CLINICAL FEATURE; CUTANEOUS PARAMETERS; DERMATOPOROSIS; ESTHETICS; HUMAN; LIFESPAN; PATHOGENESIS; REVIEW; SKIN FRAGILITY; SKIN PROTECTION; AGED; ATROPHY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN; SKIN DISEASE;

AGED; ATROPHY; HUMANS; SKIN; SKIN AGING; SKIN DISEASES;

EID: 44949096439     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. ** Saurat JH. Quand la peau devient insuffisante. Med Hyg 2004;62:476.
2. ** Saurat JH. Dermatoporosis - the functional side of skin aging. Dermatology 2007;215:271-2.
3. ** Kaya G, Saurat JH. Dermatoporosis: A chronic cutaneous insufficiency/fragility syndrome. Clinicopathological features, mechanisms, prevention and potential treatments. Dermatology 2007;215:284-94.
4. ** Kaya G, Jacobs F, Prins C, et al. Deep dissecting hematoma: An emerging severe complication of dermatoporosis. Arch Dermatol in press.
5. Schoepe S, Schacke H, May E, et al. Glucocorticoid therapy-induced skin atrophy. Exp Dermatol 2006;15:406-20.
6. Fisher GJ, Talwar HS, Lin J, et al. Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequently to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Invest 1998;101:1432-40.
7. Kelly RI, Pearse R, Bull RH, et al. The effects of aging on the cutaneous microvascufature. J Am Acad Dermatol 1995;33:749-56.
8. Chung KY, Agarwal A, Uitto J, et al. An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J Biol Chem 1996;271:3272-8.
9. Fisher GJ, Datta S, Wang Z, et al. c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid. J Clin Invest 2000;106:663-70.
10. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997;9:240-6.
11. * Calikoglu E, Sorg O, Tran C, et al. UVA and UVB decrease the expression of CD44 and hyaluronate in mouse epidermis which is counteracted by topical retinoids. Photochem Photobiol 2006;82:1342-7.
12. * Kaya G, Rodriguez I, Jorcano JL, et al. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev 1997; 11:996-1007.
13. Didierjean L, Carraux P, Grand D, et al. Topical retinaldehyde increases skin content of retinoic acid and exerts biological activity in mouse skin. J Invest Dermatol 1996;107:714-9.
14. Xiao JH, Feng X, Di W, et al. Identification of heparin-binding EGF-like growth factor as a target in intercellular regulation of epidermal basal cell growth by suprabasal retinoic acid receptors. EMBO J 1999;18:1539-48.
15. * Kaya G, Grand D, Hotz R, et al. Upregulation of CD44 and hyaluronate synthase by topical retinoids in mouse skin. J Invest Dermatol 2005;124:284-7.
16. * Kaya G, Tran C, Sorg O, et al. Retinaldehyde-induced epidermal hyperplasia via heparin binding epidermal growth factor is CD44-dependent. J Invest Dermatol 2005;124:A32.